#Pharmaceuticals
Total 5 articles
EconomyEN
Novartis SciNeuro Alzheimer Deal 2026: A $1.7 Billion Bet on Brain Health
Novartis enters a $1.7 billion Novartis SciNeuro Alzheimer deal 2026 to develop next-gen anti-amyloid treatments using blood-brain barrier shuttle technology.
EconomyEN
80% Price Cuts Hit China: The Obesity Drug Market Price War 2026
The China obesity drug price war 2026 is heating up as companies slash prices by 80%. Discover how Novo Nordisk and Eli Lilly are responding to local competition.
PRISM by Liabooks
PRISM
Advertise with Us
Place your ad in this space
[email protected]
TechEN
AstraZeneca's $100M Bet Shows China's Pharma Industry Is Flipping the Script
AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.
EconomyEN
The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China
Big Pharma faces a $171B revenue cliff. Their solution? Chinese biotech. Our analysis unpacks the high-stakes clash between economic need and geopolitical risk.
